⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Adagene Announces FDA Fast Track Designation for Muzastotug (ADG126)
globenewswire.com
ADAG
MRK
Latent Labs Announces Latent-X2: AI-Generated Antibodies With Drug-Like Developability and Low Ex Vivo Immunogenicity
businesswire.com
MRK
Insomnia Drugs Market Outlook 2026-2034: Trends, Shares, and Growth Analysis Featuring Merck & Co., Eisai Co., Viatris, Perrigo Co., Neurim Pharmaceuticals and More - ResearchAndMarkets.com
businesswire.com
MRK
VTRS
Global Polymer-Based Solubility Enhancement Excipients Market Forecast 2031: Strong CAGR of 13.1% Fueled by Pharmaceutical Innovation | Valuates Reports
prnewswire.com
AMPH
CRDF
LLY
MRK
PFE
REGN
XBI
IVD Diagnostic Molecule Raw Enzymes Market Forecast to Grow at 7.13% CAGR by 2034
globenewswire.com
TMO
MRK
Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)
businesswire.com
MRK
CGTN: How does China set tone for economic work in 2026? USA - English USA - English Korea - 한국어
prnewswire.com
BABA
JD
NTES
PDD
BIDU
XPEV
NIO
LI
BYD
AMC
CMG
MCD
SBUX
YUM
COKE
PEP
KHC
MDLZ
COST
WMT
AMZN
GOOG
MSFT
NVDA
INTC
AMD
QCOM
TSM
MU
AAPL
MS
JPM
GS
BAC
WFC
C
V
MA
AXP
BBY
HD
LOW
TJX
ROST
ULTA
LULU
NKE
UA
PVH
RL
HOG
GM
F
STLA
TM
HON
GE
CAT
DE
IBM
ORCL
SAP
CRM
ADBE
NFLX
DIS
CMCSA
VZ
T
TMUS
CHTR
SIRI
PFE
JNJ
MRK
ABBV
BMY
GILD
AMGN
LLY
BIIB
REGN
VRTX
XOM
CVX
SHEL
TTE
COP
MPC
VLO
ET
KMI
NEE
DUK
SO
EXC
AEP
SRE
PCG
ED
XEL
WEC
EIX
D
PNW
CMS
CEG
NRG
ECL
LIN
APD
DD
DOW
MMM
BA
LMT
RTX
GD
NOC
AVGO
TXN
ADI
NXPI
MRVL
ON
MCHP
ALGN
ISRG
MDT
SYK
ZBH
BAX
EW
TFX
AZN
BNTX
CRSP
EDIT
NTLA
CPRT
AZO
ORLY
LAD
CAR
AVTR
ILMN
DXCM
GOOGL
META
Fusion Proteins Market to Hit $64.9 Billion by 2030
globenewswire.com
AMGN
BMY
PFE
MRK
Acute Lymphocytic Leukemia Market: Analysis and Forecast, 2025-2035
globenewswire.com
BMY
NVS
PFE
GILD
MRK
Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Transform Treatment Landscape | DelveInsight
prnewswire.com
BNTX
NVCR
ONCO
AZN
MRK
MRUS